Yanbao Yu

Director of Proteomics

University of Delaware
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (28)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Key Points We mapped dynamic extracellular matrix remodeling in AKI and identified microfibrillar-associated protein 2 (Mfap2) as a key repair mediator. Mfap2 drove mechanometabolic signaling through a large tumor suppressor kinase 1–mediated noncanonical Hippo pathway. The Mfap2-estrogen receptor 2-3-hydroxy-3-methylglutaryl-CoA synthase 2 circuit may be a druggable node for mitigating AKI. Background Although traditionally considered a tubule-centric disorder, AKI is increasingly recognized as involving early and active participation of fibroblasts and pericytes, the primary producer of extracellular matrix (ECM). These cells are rapidly mobilized to injury sites to support repair. Therefore, successful recovery from AKI requires not only cellular regeneration but also a finely tuned ECM, which ensures structural support and transmits essential mechanical cues. Despite its importance, the mechanistic basis by which the ECM regulates AKI repair remains incompletely understood. Methods We combined genetic and pharmacologic AKI animal models with tissue engineering approaches, data-independent acquisition–based global and phosphoproteomics, and spatial transcriptomics to profile the ECM proteome landscape of decellularized kidney matrix scaffolds after injury, uncover mechanometabolic pathways driving repair, and evaluate potential therapeutic strategies. Results We generated a comprehensive proteomic map of the AKI kidney matrix scaffold and highlighted microfibrillar-associated protein 2 (Mfap2) as a key core matrisome component primarily derived from fibroblasts and pericytes. Mfap2 loss disrupted kidney architecture and metabolic homeostasis, aggravating AKI severity. Global proteomics revealed that Mfap2 deficiency downregulated tubular 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) through estrogen receptor 2 (Esr2)–mediated transcriptional repression and increased protein succinylation. Phosphoproteomic and spatial transcriptomic analysis showed that Mfap2 loss altered mechanotransduction, leading to mitogen-activated protein kinases hyperactivation and upregulation of large tumor suppressor kinase 1 in tubular cells, without affecting integrin receptor activity. Although large tumor suppressor kinase 1 is a key Hippo pathway kinase, its activation suppressed Esr2 transcription independently of the canonical yes-associated protein/transcriptional coactivator with PDZ-binding motif effectors and without affecting Esr2 degradation. Therapeutically, Esr2 agonist restored Hmgcs2 levels and improved kidney function in Mfap2 -deficient models. Conclusions Mfap2, a fibroblast/pericyte-derived core matrisome component, preserved kidney architecture and supported tubular ketogenesis by regulating Hmgcs2 via Esr2 in the AKI microenvironment.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Outer membrane-derived vesicles (OMVs) have been studied in different phyla of gram-negative bacteria, most extensively in the Pseudomonadota, where they have been shown to participate in diverse biological and environmental processes. To date, the production of OMVs has not been reported in the Chlorobiaceae within the phylum Chlorobiota. Chlorobaculum tepidum is the model organism for the Chlorobiaceae that synthesizes and consumes insoluble extracellular sulfur (S(0)) globules by an unknown mechanism. Here, we report evidence implicating outer membrane vesicles in biogenic S(0) globule synthesis. We demonstrate that Cba. tepidum secretes OMVs in the extracellular milieu and that OMV concentration and size vary with growth conditions, particularly sulfide concentration. A core of 31 proteins involved in diverse biological processes such as cell wall biogenesis, inorganic ion transport, and metabolism was found to be shared between OMVs, extracellular S(0) globules, and Cba. tepidum -intact cells. Multiple analytical methods indicated that OMVs contain S(0) and that OMVs and biogenic S(0) globules share protein and polysaccharide signatures, including lipooligosaccharides. Together, these lines of evidence indicate that Cba. tepidum ’s OMVs are one component of sulfur transport between cells and extracellular sulfur globules. IMPORTANCE All living cells must exchange material with their environment while maintaining cellular integrity. This is a particular challenge for materials that are not water-soluble; however, many bacteria utilize insoluble materials for energy conservation and as nutrients for growth. Here, we show that Cba. tepidum makes outer membrane vesicles, and these vesicles are likely involved in the exchange of material with extracellular elemental sulfur globules formed and consumed by Cba. tepidum as part of its energy metabolism based on oxidizing reduced sulfur compounds like hydrogen sulfide. These data expand our basic understanding of Cba. tepidum ’s metabolism. As elemental sulfur is an industrial by-product with a limited number of uses, the information here may help enable the use of additional sulfur compounds by Cba. tepidum to drive the synthesis of biomass and/or specialty biochemicals from waste elemental sulfur by this autotrophic bacterium.

Year:

2025

Most of Earth’s iron is mineral-bound, but it is unclear how and to what extent iron-oxidizing microbes can use solid minerals as electron donors. A prime candidate for studying mineral-oxidizing growth and pathways is Sideroxydans lithotrophicus ES-1, a robust, facultative iron oxidizer with multiple possible iron oxidation mechanisms. These include Cyc2 and Mto pathways plus other multiheme cytochromes and cupredoxins, and so we posit that the mechanisms may correspond to different Fe(II) sources. Here, S. lithotrophicus ES-1 was grown on dissolved Fe(II)-citrate and magnetite. S. lithotrophicus ES-1 oxidized all dissolved Fe 2+ released from magnetite and continued to build biomass when only solid Fe(II) remained, suggesting it can utilize magnetite as a solid electron donor. Quantitative proteomic analyses of S. lithotrophicus ES-1 grown on these substrates revealed global proteome remodeling in response to electron donor and growth state and uncovered potential proteins and metabolic pathways involved in the oxidation of solid magnetite. While the Cyc2 iron oxidases were highly expressed on both dissolved and solid substrates, MtoA was only detected during growth on solid magnetite, suggesting this protein helps catalyze oxidation of solid minerals in S. lithotrophicus ES-1. A set of cupredoxin domain-containing proteins were also specifically expressed during solid iron oxidation. This work demonstrated that the iron oxidizer S. lithotrophicus ES-1 utilized additional extracellular electron transfer pathways when growing on solid mineral electron donors compared to dissolved Fe(II). IMPORTANCE Mineral-bound iron could be a vast source of energy to iron-oxidizing bacteria, but there is limited physiological evidence of this metabolism, and it has been unknown whether the mechanisms of solid and dissolved Fe(II) oxidation are distinct. In iron-reducing bacteria, multiheme cytochromes can facilitate iron mineral reduction, and here, we link a multiheme cytochrome-based pathway to mineral oxidation, expanding the known functionality of multiheme cytochromes. Given the growing recognition of microbial oxidation of minerals and cathodes, increasing our understanding of these mechanisms will allow us to recognize and trace the activities of mineral-oxidizing microbes. This work shows how solid iron minerals can promote microbial growth, which, if widespread, could be a major agent of geologic weathering and mineral-fueled nutrient cycling in sediments, aquifers, and rock-hosted environments.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (22)

Angad P. Mehta

Assistant Professor

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Yansheng Liu

Associate Professor (Secondary)

Yale University School of Medicine

UNITED STATES
View details

Karl Schmitz

Associate Professor

University of Delaware

UNITED STATES
View details

Christopher Fields

Director, HPCBio

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Thomas Hanson

Professor

University of Delaware

UNITED STATES
View details

Clara S. Chan

Professor

University of Delaware

UNITED STATES
View details

Ramona Neunuebel

Associate Professor

University of Delaware

UNITED STATES
View details

Li Ou

Assistant Professor

University of Minnesota

UNITED STATES
View details

Anjun Ma

Assistant Professor

Ohio State University

UNITED STATES
View details

Qin Ma

Vice Chair for Research

Ohio State University

UNITED STATES
View details

Yu "Max" Qian

Associate Professor

J. Craig Venter Institute

UNITED STATES
View details

Jeffrey L Caplan

Associate Professor

University of Delaware

UNITED STATES
View details

Dong Zhou

-

UNITED STATES
View details

Zaida Luthey-Schulten

Professor

University of Illinois System

UNITED STATES
View details

Jacob Yount

Professor

Ohio State University

UNITED STATES
View details

Yuan Gui

University of Connecticut School of Medicine

UNITED STATES
View details

Jessica Tanis

Associate Professor

University of Delaware

UNITED STATES
View details

Harinder Singh

J. Craig Venter Institute

UNITED STATES
View details

Xiaolin Cheng

Associate Professor

Ohio State University

UNITED STATES
View details

John Glass

Group Leader /Professor

J. Craig Venter Institute

UNITED STATES
View details

Marcelo Freire

Associate Professor

J. Craig Venter Institute

UNITED STATES
View details

Nanqing Zhou

Northwestern University

UNITED STATES
View details